RT Journal Article SR Electronic T1 Tumor Necrosis Factor-α Inhibitor Use Is Not Associated with Lipid Changes in Rheumatoid Arthritis JF The Journal of Rheumatology JO J Rheumatol FD The Journal of Rheumatology SP 946 OP 948 DO 10.3899/jrheum.111093 VO 39 IS 5 A1 ANDRONIKI BILI A1 STEPHANIE J. MORRIS A1 JENNIFER A. SARTORIUS A1 H. LES KIRCHNER A1 JANA L. ANTOHE A1 SORINA DANCEA A1 MARY CHESTER WASKO YR 2012 UL http://www.jrheum.org/content/39/5/946.abstract AB Objective. To determine the association of use of tumor necrosis factor-α (TNF-α) inhibitors with differences in lipid levels in patients with rheumatoid arthritis (RA). Methods. We studied 807 patients with incident RA to compare differences in lipid levels in TNF-α inhibitor users versus nonusers, with adjustment for relevant covariables. Results. TNF-α inhibitor use was not associated with differences in levels of low-density lipoprotein (LDL), high-density lipoprotein (HDL), total cholesterol (TC), triglycerides, LDL:HDL, or TC:HDL compared to nonusers. Conclusion. Use of TNF-α inhibitor was not associated with differences in lipid levels in patients with RA.